Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.77B | $4.71B | $5.21B | $5.25B | $4.88B | $5.20B | $5.52B | $7.36B | $8.56B | $9.04B |
| Revenue growth | — | 24.8% | 10.6% | 0.8% | -7.1% | 6.5% | 6.3% | 33.4% | 16.3% | 5.5% |
| Gross profit | $1.46B | $1.85B | $2.03B | $2.05B | $1.83B | $1.98B | $2.08B | $2.72B | $3.21B | $3.48B |
| Gross margin | 38.8% | 39.2% | 38.9% | 39.0% | 37.5% | 38.0% | 37.7% | 36.9% | 37.5% | 38.5% |
| Operating income | $408M | $552M | $654M | $486M | $367M | $585M | $622M | $652M | $1.01B | $1.22B |
| Operating margin | 10.8% | 11.7% | 12.6% | 9.3% | 7.5% | 11.3% | 11.3% | 8.9% | 11.8% | 13.5% |
| Net income | $260M | $331M | $549M | $401M | $254M | $427M | $355M | $609M | $890M | $957M |
| Net margin | 6.9% | 7.0% | 10.5% | 7.6% | 5.2% | 8.2% | 6.4% | 8.3% | 10.4% | 10.6% |
| EPS (diluted) | $1.45 | $1.83 | $3.03 | $2.21 | $1.40 | $2.35 | $1.96 | $2.79 | $3.65 | $3.92 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $497M | $686M | $586M | $839M | $824M | $538M | $596M | $837M | $1.26B | $1.24B |
| Capital expenditures | $124M | $170M | $237M | $226M | $183M | $208M | $208M | $271M | $321M | $331M |
| Free cash flow | $373M | $516M | $349M | $613M | $641M | $330M | $388M | $566M | $942M | $910M |
| Share buybacks | $4.00M | $25.0M | $59.0M | $40.0M | $61.0M | $68.0M | $52.0M | $25.0M | $20.0M | $15.0M |
| Dividends paid | $112M | $130M | $152M | $174M | $188M | $203M | $217M | $299M | $350M | $391M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $308M | $414M | $296M | $724M | $1.88B | $1.35B | $944M | $1.02B | $1.12B | $1.48B |
| Total assets | $6.47B | $6.86B | $7.22B | $7.71B | $8.75B | $8.28B | $7.95B | $16.1B | $16.5B | $17.6B |
| Total liabilities | $4.27B | $4.34B | $4.44B | $4.74B | $5.77B | $5.05B | $4.45B | $5.94B | $5.61B | $5.88B |
| Long-term debt | $2.11B | $2.20B | $2.05B | $2.04B | $2.48B | $2.44B | $1.88B | $2.27B | $1.98B | $1.41B |
| Shareholders' equity | $2.19B | $2.50B | $2.77B | $2.96B | $2.97B | $3.22B | $3.49B | $10.2B | $10.6B | $11.5B |
| Retained earnings | $1.03B | $1.23B | $1.64B | $1.87B | $1.93B | $2.15B | $2.29B | $2.60B | $3.14B | $3.71B |
| Shares (wtd avg diluted) | 180M | 181M | 181M | 181M | 181M | 182M | 181M | 218M | 244M | 244M |
Every figure is extracted from Xylem Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.